Citra-Lock™ 46,7% (trisodium-citrate) The superior way to lock every catheter

Citra-Lock™ 46,7% 5ml vial:

1. Anti-microbial
2. Anti-coagulant
3. Anti-biofilm
4. Avoids heparin-associated bleedings
5. Lower tPa utilization rate and cost
6. Reduces mrsa bloodstream infections
7. Safe for heparin induced thrombocytopenia (hit patients)

Citra-Lock™ (Trisodium citrate 46,7%)

REFERENCES:
1. Winnet G (2008) Trisodium citrate (TSC) 46.7% selectively and safely reduces staphylococcal. Nephrol Dial Transplant 10: 1093-1100
2. Weijmer MC (2005) Randomized, Clinical Trial Comparison of Trisodium Citrate 30% and Heparin as Catheter-Locking Solution in Haemodialysis Patients.
J Am Soc Nephrol. Sep;16(9):2769-77
3. Weijmer MC (2002) Superior Antimicrobial Activity of Trisodium Citrate over Heparin for Catheter Locking. Nephrol Dial Transplant 17: 2189-2195
4. Shanks RM (2006) Catheter Lock Solutions Influence Staphylococcal Biofilm Formation on Abiotic Surfaces. Nephrol Dial Transplant 21, 2247-2255
5. Ash SR (2000) Concentrated Sodium Citrate (23%) for Catheter Lock. Haemodialysis International 4:22-31
6. Nolan JP (2007) Reducing Catheter Related Bacteraemia in Haemodialysis. Vascular Access Soc. 5th Int. Congress of Vascular Access Soc, Nice

Also Available:
Citra-Lock™ 4%
Citra-Flow™ 4%
Citra-Lock™ 30%

Citra-Lock™ and Citra-Flow™ are registered as a medical device (Class IIb)